These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 9779694)

  • 1. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?
    Ripamonti C; Groff L; Brunelli C; Polastri D; Stavrakis A; De Conno F
    J Clin Oncol; 1998 Oct; 16(10):3216-21. PubMed ID: 9779694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study.
    Lawlor PG; Turner KS; Hanson J; Bruera ED
    Cancer; 1998 Mar; 82(6):1167-73. PubMed ID: 9506365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study.
    Mercadante S; Casuccio A; Fulfaro F; Groff L; Boffi R; Villari P; Gebbia V; Ripamonti C
    J Clin Oncol; 2001 Jun; 19(11):2898-904. PubMed ID: 11387363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid switching from morphine to methadone in cancer patients with poor response to morphine.
    Mercadante S; Casuccio A; Calderone L
    J Clin Oncol; 1999 Oct; 17(10):3307-12. PubMed ID: 10506634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid plasma concentration during switching from morphine to methadone: preliminary data.
    Mercadante S; Bianchi M; Villari P; Ferrera P; Casuccio A; Fulfaro F; Gebbia V
    Support Care Cancer; 2003 May; 11(5):326-31. PubMed ID: 12690541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose ratios between high dose oral morphine or equivalents and oral methadone.
    Chatham MS; Dodds Ashley ES; Svengsouk JS; Juba KM
    J Palliat Med; 2013 Aug; 16(8):947-50. PubMed ID: 23662952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching from methadone to a different opioid: what is the equianalgesic dose ratio?
    Walker PW; Palla S; Pei BL; Kaur G; Zhang K; Hanohano J; Munsell M; Bruera E
    J Palliat Med; 2008 Oct; 11(8):1103-8. PubMed ID: 18980450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to switch from morphine or oxycodone to methadone in cancer patients? a randomised clinical phase II trial.
    Moksnes K; Dale O; Rosland JH; Paulsen O; Klepstad P; Kaasa S
    Eur J Cancer; 2011 Nov; 47(16):2463-70. PubMed ID: 21775131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences.
    Ripamonti C; De Conno F; Groff L; Belzile M; Pereira J; Hanson J; Bruera E
    Ann Oncol; 1998 Jan; 9(1):79-83. PubMed ID: 9541687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone titration in opioid-resistant cancer pain.
    Scholes CF; Gonty N; Trotman IF
    Eur J Cancer Care (Engl); 1999 Mar; 8(1):26-9. PubMed ID: 10362950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine.
    Bruera E; Pereira J; Watanabe S; Belzile M; Kuehn N; Hanson J
    Cancer; 1996 Aug; 78(4):852-7. PubMed ID: 8756381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ad libitum schedule for conversion of morphine to methadone in advanced cancer patients: an open uncontrolled prospective study in a Chinese population.
    Tse DM; Sham MM; Ng DK; Ma HM
    Palliat Med; 2003 Mar; 17(2):206-11. PubMed ID: 12701853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of methadone in opioid rotation-a Polish experience.
    Leppert W
    Support Care Cancer; 2009 May; 17(5):607-12. PubMed ID: 19043743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.
    Clemens KE; Klaschik E
    Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid switch to oral methadone in cancer pain.
    Mancini I; Lossignol DA; Body JJ
    Curr Opin Oncol; 2000 Jul; 12(4):308-13. PubMed ID: 10888415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid switching from oral slow release morphine to oral methadone may improve pain control in chronic non-malignant pain: a nine-month follow-up study.
    Fredheim OM; Kaasa S; Dale O; Klepstad P; Landrø NI; Borchgrevink PC
    Palliat Med; 2006 Jan; 20(1):35-41. PubMed ID: 16482756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose.
    Mercadante S; Villari P; Ferrera P; Bianchi M; Casuccio A
    J Pain Symptom Manage; 2004 Apr; 27(4):352-9. PubMed ID: 15050663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
    Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
    J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.